Community/Retail

The House investigational hearing drew testimony from health care industry experts representing insurers, patient advocacy groups, and pharmaceutical companies.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The 17% drop is the biggest ever recorded in the United States market, according to the IQVIA Institute for Human Data Science.

Bernard Marini, PharmD, BCOP, an Inpatient Hematology Specialist at the University of Michigan, discusses the selection of therapies for patients with acute myeloid leukemia, during the Hematology/Oncology Pharmacy Association's 2019 annual meeting in Fort Worth, Texas.

Lawmakers said the generic and biosimilar manufacturers depend on the 2 databases to bring more affordable medications to the market.

According to Sandoz, the company is working to make its epinephrine 0.3 mg and 0.15 injections available to the retail market, which would enable individuals to obtain this medicine at local pharmacies.

In announcing the requirement, Health and Human Services Secretary Alex Azar said Americans deserve to know the prices of the medications they receive.

Positive results were collected from a Phase 3 study of an investigational fixed-dose combination nasal spray for the treatment of seasonal allergic rhinitis (SAR), according to Glenmark Pharmaceuticals.

The national retail chain is also providing a more wholesome assortment of pet foods and the company is expanding in-store veterinary clinics.

Jaron Stout, PharmD, owner, consulting pharmacist, Collaborative Pharmacy Consultants, discusses the benefits of pharmacist services and a personal success story. This video was filmed at the American Society of Consultant Pharmacists' 2019 Forum in Washington, DC.

Suzanne Soliman, PharmD, founded the Pharmacist Mom Group on Facebook, and it has since grown to be 1 of the most active on the popular social media platform, with more than 2 million posts last year alone.

Those recognized were selected by a panel of judges from more than 15,000 customer-submitted entries in October 2018, during American Pharmacists Month.

A study in 2008 showed that approximately 5.2% of US adults age 18-80 years used benzodiazepines.

Amber Draper, PharmD, BCOP, clinical pharmacist, Winship Cancer Institute in Georgia discusses educating patients about lifestyle and dietary factors that increase risk of colon cancer. This video was filmed at the 2019 Hematology/Oncology Pharmacy Association Annual Conference in Fort Worth, Texas.

Although the prevalence of LEMS in children is not known, the overall prevalence is estimated to be 3 per million individuals worldwide, according to the FDA.

When applying for the grant for Realo Discount Drug’s Transition to Wellness Program, Christina Nunemacher's goal was to show that involving pharmacists in the hospital discharge process could lower readmission rates.

Health care professionals provide their considerations regarding the future of measles prevention and management.

Prior to this approval, there were no available treatments for ATTR-CM, only symptom management and, in rare cases, heart transplant.

How did a man with low sperm county get his wife pregnant?

Dapagliflozin is a selective sodium‑glucose cotransporter-2 (SGLT-2) inhibitor that is combined with a dipeptidyl peptidase‑4 (DPP‑4) inhibitor, saxagliptin; and metformin hydrochloride extended release.

Jaron Stout, PharmD, owner, consulting pharmacist, Collaborative Pharmacy Consultants, discusses collaborative practice agreements and how they vary between states. This video was filmed at the American Society of Consultant Pharmacists' 2019 Forum in Washington, DC.

Can omega 3 oils calm inflamation?

Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.

Dana Saffel, PharmD, CEO of Pharmacare Strategies, discusses various crushing systems and USP 800 compliance during the American Society of Consultant Pharmacists in Washington, DC.

In the first and largest study of its kind, researchers from the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute aimed to assess mortality associated with beta interferons for the treatment of MS.

The FDA rapidly reviewed and approved Genentech’s application under the FDA’s Real-Time Oncology Review (RTOR) and Assessment Aid pilot programs, leading to an approval 12 weeks after completing the submission.

Results of the recent study, published in The Lancet, support the benefits of early testing and treatment for HIV, as well as the message of Prevention Access Campaign’s U=U (undetectable equals untransmittable) initiative.

Lisa Holle, PharmD, BCOP, FHOPA, associate clinical professor at the University of Connecticut, explains the importance of patient-provider communication during the 2019 Hematology/Oncology Pharmacy Association conference in Fort Worth, Texas.

Measles cases are increasing at an alarming rate, and the antivaccination movement has helped bring back this potentially deadly disease that was once eliminated in the United States.

Teva Pharmaceutical Industries has launched a generic version of Gilead’s Letairis (ambrisentan) Tablets, 5 mg and 10 mg, in the United States.